By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a




Company News
Immune Pharma Announces Formation Of Management Team For Maxim Pharmaceuticals, Inc. (MAXM), Its Pain And Neurology Subsidiary 10/17/2016 11:02:16 AM
Immune Pharma Signs Agreement To Fund Maxim Pharmaceuticals, Inc. (MAXM), Its Pain And Neurology Subsidiary 9/16/2016 8:41:28 AM
Immune Pharma Receives $2 Million Investment In Common Stock At $0.50 Per Share 9/7/2016 9:31:11 AM
Immune Pharma Provides Business And R&D Update And Announces Second Quarter 2016 Financial Results 8/16/2016 12:14:53 PM
Immune Pharma to Form Pain and Neurology Spin Off Company Around AmiKet 7/19/2016 7:47:02 AM
Immune Pharma Release: New Data Suggests Improved Tumor Response For The Combination of AZIXA and Immune Checkpoint Inhibitors in The Treatment of Cancer 6/28/2016 6:12:57 AM
Immune Pharma Release: New Data Shows That Ceplene Enhances Response To Anti PD-1 And Anti-PD-L1 Immune Checkpoint Inhibitors In Lymphoma And Solid Tumor Models 6/21/2016 6:14:38 AM
Immune Pharma To Present At The JMP Securities Life Sciences Conference On June 21, 2016 6/20/2016 7:34:25 AM
Immune Pharma Expands Its Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid To Six Academic Institutions In The United States 6/15/2016 10:11:18 AM
Immune Pharma And Hadasit Ltd. File A Joint Patent On The Oral Use Of Anti-Eotaxin Monoclonal Antibodies, Including Bertilimumab, For The Treatment Of GI And Liver Diseases 6/8/2016 7:47:10 AM